Skip to content
10-K

Annual Report

ANAVEX LIFE SCIENCES CORP. AVXL

0001731122-24-002041

← back to feed
Filed
Dec 23, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Dec 23, 2024 84.82M sh
Cash And Equivalents FY 2024 · Sep 30, 2023 $151.02M
Total Liabilities FY 2024 · Sep 30, 2023 $12.53M
Total Assets FY 2024 · Sep 30, 2023 $154.39M